| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.13B | +7.7% | +6.7% |
| R&D Expense | $198.2M | +4.3% | -0.9% |
| SG&A Expense | $530.6M | +48.1% | +62.9% |
| Operating Income | $57.5M | +108.4% | -77.9% |
| Pre-tax Income | $9.0M | +101.2% | -95.5% |
| Income Tax | -$242.4M | -1311.9% | -1568.1% |
| Net Income | $251.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.33B | +11.4% | -40.2% |
| Accounts Receivable | $764.4M | +7.1% | +5.6% |
| Inventory | $483.1M | -4.3% | -10.4% |
| Current Assets | $3.76B | +12.1% | -14.5% |
| Total Assets | $11.36B | +3.8% | -7.3% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $993.3M | — | — |
| Capital Expenditures | $42.0M | — | — |
| Investing Cash Flow | -$1.14B | — | — |
| Financing Cash Flow | -$948.8M | — | — |
| Free Cash Flow | $951.2M | — | — |
| +135.0% |
| +16.9% |
| EPS (Basic) | $4.14 | +135.3% | +18.3% |
| EPS (Diluted) | $4.08 | +134.8% | +19.3% |
| $2.27B |
| +9.8% |
| +120.8% |
| Long-term Debt | $5.36B | -0.1% | -12.3% |
| Stockholders' Equity | $3.96B | +6.8% | -5.1% |